Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Ovarian Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Fallopian Tube Neoplasms 2Triple Negative Breast Neoplasms 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-sensitive Prostate Cancer 1Hemangiosarcoma 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Biliary Tract Neoplasms 1

Interventions

niraparib 1Prednisone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Castration-sensitive Prostate Cancer × niraparib × 30 days × Clear all
NCT04497844 2026-05-11

AMPLITUDE

Janssen Research & Development, LLC

Phase 3 Active not recruiting
696 enrolled 15 charts 1 FDA
Genitourinary

Metastatic Castration-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡